[Virus-like particles as cancer vaccine. Great expectations--not only for papillomavirus associated cancer].
Tegerstedt
Karin
K
Karolinska Universitetssjukhuset.
Andreasson
Kalle
K
Dahlstrand
Hanna
H
Ramqvist
Torbjörn
T
Dalianis
Tina
T
D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control / Q000821:virology; D019496:Cancer Vaccines / Q000008:administration & dosage*; D005260:Female; D018734:Genes, erbB-2 / Q000235:genetics; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009374:Neoplasms, Experimental / Q000235:genetics / Q000517:prevention & control / Q000821:virology; D009856:Oncogene Proteins, Viral / Q000737:chemistry / Q000235:genetics; D027383:Papillomaviridae / Q000648:ultrastructure; D030361:Papillomavirus Infections / Q000235:genetics / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D014067:Tonsillar Neoplasms / Q000235:genetics / Q000517:prevention & control / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000235:genetics / Q000517:prevention & control / Q000821:virology; D014765:Viral Vaccines / Q000008:administration & dosage*
D019496:Cancer Vaccines; D009856:Oncogene Proteins, Viral; D053918:Papillomavirus Vaccines; D014765:Viral Vaccines